Suscribirse

Staphylococcus Aureus Bacteremia Among Patients with Health Care-associated Fever - 12/08/11

Doi : 10.1016/j.amjmed.2008.09.040 
Martin E. Stryjewski, MD, MHS a, d, , Zeina A. Kanafani, MD e, Vivian H. Chu, MD a, b, Paul A. Pappas, MS a, Tina Harding, BSN a, Laura A. Drew, RN, BSN a, Daniel K. Benjamin, MD, PhD, MHS a, c, L. Barth Reller, MD b, Benjamin A. Lee, BA a, G. Ralph Corey, MD a, b, Vance G. Fowler, MD, MHS a, b
a Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 
b Department of Medicine, Duke University Medical Center, Durham, NC 
c Department of Pediatrics, Duke University Medical Center, Durham, NC 
d Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Buenos Aires, Argentina 
e Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon 

Requests for reprints should be addressed to Martin E. Stryjewski, MD, MHS, Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”, Azcuenaga 1757, Apt 1C, Capital Federal (C1128AAC), Buenos Aires, Argentina

Abstract

Background

Although Staphylococcus aureus bacteremia is a common, serious infection, accurately identifying febrile patients with this diagnosis at the time of initial evaluation is difficult. The purpose of this investigation was to define clinical characteristics present at the time of the initial recognition of fever that were associated with the presence of any bloodstream infection and, in particular, with S. aureus bacteremia.

Methods

All patients ≥18 years of age with a new episode of health care-associated fever (temperature ≥38°C) and at least one blood culture drawn were eligible for enrollment into this prospective multicenter cohort study. Multivariable analyses were conducted and internally validated scoring systems were developed to categorize the risk of bacteremia.

Results

Of 1015 patients enrolled, 181 patients (17.8%) had clinically significant bacteremia, including 77 patients (7.6%) with S. aureus bacteremia. Clinical characteristics associated with S. aureus bacteremia were the presence of a hemodialysis graft or shunt (odds ratio [OR] 3.22; 95% confidence interval [CI], 1.85-5.61), chills (OR 2.38; 95% CI, 1.43-3.98), and a history of S. aureus infection (OR 2.68; 95% CI, 1.38-5.20). Peripheral vascular catheters were inversely associated with S. aureus bacteremia (OR 0.42; 95% CI, 0.26-0.69). Clinical characteristics associated with any bloodstream infection were central venous access, chills, history of S. aureus infection, and hemodialysis access.

Conclusions

Among patients with health care-associated fever, the presence of easily recognizable clinical characteristics at the time of obtaining the initial blood cultures can help to identify patients at increased risk for any bloodstream infection, in particular for S. aureus bacteremia.

El texto completo de este artículo está disponible en PDF.

Keywords : Bacteremia, Fever, Health care, S. aureus, Score


Esquema


 Funding: This work was supported by a grant from Inhibitex, Inc. Inhibitex did not intervene in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
 Conflicts of Interest: Martin E. Stryjewski has consulted for Astellas (<$10,000), and has received a research grant (>$10,000) and is a consultant for Theravance Inc. (>$10,000/year). Vivian H. Chu has received a research grant from Theravance Inc. Vance G. Fowler has received research funding from Theravance, Merck, Nabi (<US$10,000/year), Inhibitex, Cubist, and the National Institute of Health; is a consultant for Biosynexus, Inhibitex, Merck, Cerexa, and Cubist; and is on the speaker's bureaus for Cubist and Pfizer. G. Ralph Corey has received research funding from Theravance, Cubist, Merck, and Inhibitex; and is a consultant for Cubist, Inhibitex, Cerexa, and Pfizer. Daniel K. Benjamin Jr. has received a research grant from Nabi, Cape Cod Associates, Astellas, MedImmune, Pediatrix, Rockeby, National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases. Tina Harding, Laura A. Drew, Paul A. Pappas, Benjamin A. Lee, Zeina A. Kanafani, and L. Barth Reller have no conflicts.
 Authorship: All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.


© 2009  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 122 - N° 3

P. 281 - mars 2009 Regresar al número
Artículo precedente Artículo precedente
  • Elevated Body Mass Index and Use of Coronary Revascularization after Cardiac Catheterization
  • Kathryn M. King, Danielle A. Southern, Jacques Cornuz, Andrew Maitland, Merril L. Knudtson, William A. Ghali
| Artículo siguiente Artículo siguiente
  • Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
  • David S. Wald, Malcolm Law, Joan K. Morris, Jonathan P. Bestwick, Nicholas J. Wald

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.